Flutamide

Product manufactured by Cipla Usa Inc.

Application Nr Approved Date Route Status External Links
ANDA075780 None Oral None Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

Indications And Usage Flutamide Capsules Are Indicated For Use In Combination With Lhrh Agonists For The Management Of Locally Confined Stage B 2 -C And Stage D 2 Metastatic Carcinoma Of The Prostate. Stage B2-C Prostatic Carcinoma Treatment With Flutamide Capsules And The Goserelin Acetate Implant Should Start 8 Weeks Prior To Initiating Radiation Therapy And Continue During Radiation Therapy. Stage D2 Metastatic Carcinoma To Achieve Benefit From Treatment, Flutamide Capsules Should Be Initiated With The Lhrh Agonist And Continued Until Progression.

All Formulated Excipients (0 Total)

None

Active Ingredients ( 1 Total)

Name Structure ZINC ID(s)
1. Flutamide FLUTAMIDE ZINC3812944

Comments